At CPHI in Milan in October, eight Indian CDMOs announced that they have formed a trade group to raise the profile of India’s drug services…
News Category: Media
Biotech Industry’s Path Towards Sustainability
1. How critical is sustainability to your company’s long-term strategy, and what are the primary goals you’ve set in this area? Sustainability is integral to…
Navigating the future: building a de-risked supply chain
As the global supply chain landscape continues to evolve, the potential enactment of the BIOSECURE Act has raised significant concerns, particularly in the pharmaceutical and…
IRA matches BIOSECURE in driving CDMO sector in India
The biggest story affecting the pharma supply chain of 2024 is arguably the BIOSECURE Act. The bipartisan Act, which passed through the US House of…
Automation accelerators in drug discovery and development
Digital transformation is paving way for improved efficiency and efficacy in pharmaceutical industry. With changing global business environment and shortage of resource dexterities — automation…
Unpacking Global Biopharma Business Relations with Ashu Tandon
Ashu Tandon, Chief Commercial Officer and Management Council member at Aragen, has over 25 years of experience working in the biopharma business. This shows itself…
Aragen $100m PE boost to bolster CDMO ambition in India and beyond
Indian CDMO Aragen has laid out aggressive expansion plans for capacity and multi-modality services following a $100 million investment from Singapore-based private equity (PE) fund…
2025 – The year ahead
It’s that time of year again when we take stock of the advances the biopharma industry has made and look ahead to the evolving client…
Targeted protein degraders: Blood–brain barrier permeability and central nervous system exposure
Abstract Innovative approaches are essential for treating central nervous system (CNS) diseases that present severe neurological manifestations and low survival rates. Delivering chemical or biological…
India’s Aragen sees rising demand for CRDMO services amid changes in geopolitical landscape
As an India-based contract research, development, and manufacturing organization (CRDMO), Aragen Life Sciences stands to benefit as the biopharma industry looks to derisk its supply…